Paul Tudor Jones Says Theres No Chance Kevin Warsh Could Push the Fed to Cut Rates Market Speculation Swirls Around Potential Shift from Quarterly Earnings Reports Citius Pharmaceuticals CTXR A Penny Stock Option Among Wall Street Analyst Favorites Traders Shift Rate Expectations Feds Next Move Could Be a Hike as Soon as December Oil Supply Crunch Expected Later Than Initially Anticipated Brookings Study Examines Data Center Employment Impact on Local Economies Celestica CLS Q1 2026 Earnings EPS Surprises to the Upside as Shares Gain Edgewise Therapeutics Inc EWTX Q1 2026 Earnings Narrowerthanexpected loss underscores disciplined RD execution Deckers Outdoor DECK Q1 2026 Earnings Ugg and Hoka Drive DoubleDigit EPS Beat Revenue Details Withheld CNTX Q1 2026 Earnings Narrower Loss Surprises Shares Advance Over 13 ATLCP Q1 2026 Earnings Earnings Per Share Surpasses Estimates by Nearly 26 KALV Q1 2026 Earnings Narrower Loss Beats Expectations Clinical Pipeline Progress Underway Columbia Sportswear COLM Rallies 38 as Shares Bounce From Key Support Level RYTHM Inc RYM Faces Pressure Down 3 as Key Support Levels Loom Old Republic International ORI Edges Lower Remains Within Established Range C1 Fund Inc CFND Edges Lower Amid Modest Declines Support and Resistance Levels in Focus BankUnited BKU Gains 214 Regional Bank Strength Tests Key Resistance Zone SP 500 Creeps Higher as Healthcare and Tech Lead Communication Services Lags Bitcoin Drops Below 77000 Amid Escalating USIran Tensions and Spot ETF Outflows Enphase Energy Shares Surge 137 Following Goldman Sachs Optimistic Outlook Bond Markets Bet on Sustained Inflation Raising Pressure on Washington Policymakers Crude Oil Surges 3 as TrumpIran Tensions Rekindle Strait of Hormuz Risk Premium Indias Parody Cockroach Party Claims Website Blocked Amid Digital Content Scrutiny T Stamp IDAI Q1 2026 Earnings EPS Miss Widens as Revenue Details Remain Undisclosed Definium Therapeutics DFTX Gains Ground as Stock Approaches Key Resistance Level